Safety and Efficacy of the Complement Inhibitor AMY-101 (Cp40) in a Natural Model of Periodontitis in Non-Human Primates
Molecular Therapy - Methods and Clinical Development - United States
doi 10.1016/j.omtm.2017.08.001
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2017
Authors
Publisher
Elsevier BV